Skip to content
Nonprofiteer
← COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANC

Form 990 for tax year 2024

Filed by COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANC.

Totals

Total revenue
$311,413
Total expenses
$132,254
Contributions and grants received
$98,527
Grants paid
$30,000
Program service revenue
$194,440
Investment income
$18,446
Other revenue
$0
Total assets, end of year
$808,388
Total liabilities, end of year
$15,434
Net assets or fund balances, end of year
$792,954
Program services expenses (Part IX)
$132,254
Management and general expenses
$0
Fundraising expenses
$0
Program service expenses (Part III)
$132,254

Program services were 100.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Revenue

Part VIII, the statement of revenue.

  • 1b · Membership dues

    $62,130

  • 1f · All other contributions, gifts and grants

    $36,397

  • 2a · Program service revenue: CONGRESS INCOME

    total $186,940 · related or exempt $186,940

  • 2b · Program service revenue: SCHOLARSHIPS

    total $7,500 · related or exempt $7,500

  • 3 · Investment income

    total $18,446 · related or exempt $18,446

Functional expenses

Part IX, the statement of functional expenses.

  • 2 · Grants to domestic individuals

    total $30,000 · program services $30,000

  • 11a · Fees: management

    total $44,400 · program services $44,400

  • 13 · Office expenses

    total $9,869 · program services $9,869

  • 24a · Other expenses: MEETING EXPENSE

    total $35,650 · program services $35,650

  • 24b · Other expenses: WEBSITE

    total $5,633 · program services $5,633

  • 24c · Other expenses: EDUCATIONAL EXPENSES

    total $4,459 · program services $4,459

  • 24d · Other expenses: AWARDS

    total $1,294 · program services $1,294

  • 24e · All other expenses

    total $949 · program services $949

Balance sheet

Part X, book values.

  • 1 · Cash, non-interest-bearing

    beginning of year $200,085 · end of year $255,233

  • 2 · Savings and temporary cash investments

    beginning of year $400,000 · end of year $400,000

  • 4 · Accounts receivable

    beginning of year $50,654 · end of year $153,155

  • 17 · Accounts payable and accrued expenses

    beginning of year $36,944 · end of year $15,434

  • 27 · Net assets without donor restrictions

    beginning of year $613,795 · end of year $792,954

Mission and programs · 2024

Mission

THE MISSION OF THE COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS TO OFFER: -EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS, ALLIED HEALTHCARE PROFESSIONALS, PATIENTS, AND THEIR FAMILIES. -ACCESS TO COLLABORATIVE TRIALS AND STUDIES. -RESOURCES FOR DEVELOPING NEW HEREDITARY REGISTRIES AND SUPPORTING THEIR REGISTRIES. -A FORUM FOR EXCHANGE OF IDEAS. -MULTIDISCIPLINARY EXPERTISE IN CLINICAL CARE, HEALTHCARE POLICY, AND RESEARCH RELATED TO HEREDITARY GASTROINTESTINAL CANCER.

Activities or mission (Part I)

THE CGA FOCUSES ON THE HEALTHCARE, EDUCATION AND COLLABORATIVE RESEARCH OF FAMILIES WITH RARE FORMS OF INHERITED GASTROINTESTINAL CANCER.

  • COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER IS DEVOTED TO THE PURSUIT OF PROVIDING CUTTING EDGE EDUCATION REGARDING THE CLINICAL MANAGEMENT AND MOLECULAR GENETICS OF INHERITED GASTROINTESTINAL CANCER TO PHYSICIANS AND ALLIED HEALTH CARE PROFESSIONALS. THIS IS ACHIEVED PRIMARILY THROUGH CONTINUING MEDICAL EDUCATION AND BY PROVIDING A FORUM FOR THE EXCHANGE OF IDEAS AT THE ANNUAL MEETING. COLLABORATIVE GROUP OF THE AMERICAS ON INHERITED GASTROINTESTINAL CANCER AIMS TO ENCOURAGE PROFESSIONAL GROWTH, SIMULATE INTELLECTUAL CURIOSITY, AND IMPROVE PATIENT OUTCOMES BY EXPANDING ACCESS TO UP-TO-DATE INFORMATION OF INTEREST TO PRACTITIONERS AND RESEARCHERS. THE ANNUAL MEETING IS DESIGNED TO KEEP CLINICIANS AND SCIENTISTS UP-TO-DATE ON NEW DEVELOPMENTS IN HEREDITARY GASTROINTESTINAL CANCER RESEARCH, INCLUDING IMPLICATIONS IN THE PREVENTION, DIAGNOSIS, AND TREATMENT OF PATIENTS WITH THE HEREDITARY GASTROINTESTINAL CANCER SYNDROMES. THE PROGRAM IS DIRECTED TO COLORECTAL SURGEONS, MEDICAL ONCOLOGISTS, GASTROENTEROLOGISTS, RESEARCHERS, GENETICISTS, NURSES, COLORECTAL CANCER REGISTRY COORDINATORS, GENETIC COUNSELORS, PSYCHOLOGISTS AND OTHER HEALTH CARE PROFESSIONALS INVOLVED IN THE CARE OF INDIVIDUALS WITH HEREDITARY GASTROINTESTINAL CANCERS, INCLUDING COLORECTAL, ESOPHAGEAL, PANCREATIC, GASTRIC AND SMALL BOWEL CANCERS.

    Expenses $132,254 · Grants $30,000 · Revenue $194,440

As filed on the 2024 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

  • Bryson Katona MD PhD Cgaf

    PRESIDENT

    Total calculated
    $0

  • Pete Stanich MD

    PAST PRESIDE

    Total calculated
    $0

  • Michael Hall MD Ms Cgaf

    TREASURER

    Total calculated
    $0

  • Beth Yurkovich Ms MPH Cgc Cgaf

    PRESIDENT EL

    Total calculated
    $0

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type
form_990
Tax year
2024
Filed
15 November 2025
IRS schema version
2024v5.0
Source object
202503219349301990

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.